Schubert & CO Jazz Pharmaceuticals PLC Transaction History

Schubert & CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	SELL	$133.98 - $160.47 $1,071 - $1,283	-8 Reduced 29.63%	19 $2,000
Q4 2022 Jan 31, 2023	BUY	$129.72 - $159.85 $1,167 - $1,438	9 Added 50.0%	27 $4,000
Q3 2022 Oct 21, 2022	SELL	$126.59 - $161.18 $1,645 - $2,095	-13 Reduced 41.94%	18 $2,000
Q2 2022 Aug 01, 2022	BUY	$141.59 - $168.66 $2,831 - $3,373	20 Added 181.82%	31 $5,000
Q1 2022 May 16, 2022	BUY	$129.64 - $160.7 $388 - $482	3 Added 37.5%	11 $2,000
Q4 2021 Jan 28, 2022	BUY	$119.87 - $145.67 $958 - $1,165	8 New	8 $1,000

512

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Schubert & CO, based on Form 13F filings with the SEC.

Stay updated on Schubert & CO with notifications on news.